Concepedia

James P. Kemp

JP

64

Publications

4.5K

Citations

35

H-Index

1982

Active since

Affiliations

Allergy and Asthma Medical Group and Research Center(Current)

University of California San Diego

Research Triangle Park Foundation

University of North Carolina at Chapel Hill

James P. Kemp is an author at Allergy and Asthma Medical Group and Research Center specializing in medicine, asthma, and allergy.

ORCID

Top concepts

Publications per year

1982–2023

64

Publications

64

Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction

Jonathan A. Leff, David S. Pearlman, Edwin A. Bronsky et al. · New England Journal of Medicine · 1998 · 555 citations · Full text

A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma

David S. Pearlman, Paul Chervinsky, Craig LaForce et al. · New England Journal of Medicine · 1992 · 362 citations

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.

Kwang Ho In, Kazuhito Asano, David R. Beier et al. · Journal of Clinical Investigation · 1997 · 336 citations · Full text

, , +14

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

James P. Kemp, Robert J. Dockhorn, Gail G. Shapiro et al. · The Journal of Pediatrics · 1998 · 272 citations

, , +8

Oral Montelukast Compared with Inhaled Salmeterol To Prevent Exercise-Induced Bronchoconstriction

Jonathan M. Edelman, Jennifer Turpin, Edwin A. Bronsky et al. · Annals of Internal Medicine · 2000 · 215 citations

Rows per page

1–5 of 64